Your Cart Is Empty!
Market barriers affect nearly 25% of growth hormone prescriptions in Europe, costing most brands market share.
But one brand’s efforts to overcome the three biggest barriers have helped it siphon share from competitors—especially the leading brand.
Find out how barriers affect your brand in Market Access Impact: GHD.
The report covers 7 major growth hormone brands: Genotropin, Humatrope, Norditropin, NutropinAq, Omnitrope, Saizen, and Zomacton.
You’ll learn which barriers cost you the most share, which brands you’re losing it to, and which ones you’re taking it from—information you can use to improve your market access strategy
Get Answers to Key Questions about Growth Hormone Brands
Genotropin (somatropin; Pfizer): Which barrier do more doctors experience with Genotropin than with any other brand?
Humatrope (somatropin; Eli Lilly): Which leading brand takes more market share from Humatrope than any other brand?
Norditropin (somatropin; Novo Nordisk): Which brand is easier to get reimbursed, Norditropin or Omnitrope?
Omnitrope (somatropin; Sandoz): Is pricing or formulary availability driving bigger share gains for Omnitrope?
Saizen (somatropin; Merck KGaA): Is brand awareness a bigger issue for Saizen or NutropinAq?
Zomacton (somatropin; Ferring): Zomacton has roughly as much market share as “other” brands (not surveyed). Would eliminating market barriers tip the scales in its favour?
Winning market strategy for one brand. Breaking down key barriers earned one brand net share gains against five competitors, and the second largest net share gain overall.
Few brands come out ahead. While a fair amount of market share is changing hands because of barriers, only three brands see a net gain.
Cost, guidelines, and market access have the greatest impact. Barriers related to these factors affect more prescriptions than any others.
Eliminating barriers would tighten up the market, knocking the top 3 brands down a bit and pushing the bottom 4 brands up—mostly at the expense of “other” brands.
“Other” brands win big. In aggregate, other brands (not surveyed) see largest barrier-related share gain—more than twice as much as any surveyed brand.
Europe less active than the US. Only one of the seven surveyed brands is prescribed more in the EU5 countries.
Top 3 brands are the same in Europe and the US. Endocrinologists in both markets most often prescribe the same three leading brands.
Market Access Impact: GHD explores key issues affecting Growth Hormone manufacturers. You’ll learn:
How barriers affect market access:
What brands do doctors prescribe the most?
How many prescriptions do barriers affect?
Which barriers have the biggest impact?
How barriers affect your brand:
How many doctors prescribe your brand? How many don’t, but would consider it?
Why don’t doctors prescribe your brand? What do they prescribe instead?
Which competing brands does your brand take market share from?
A Report Based on Expert Knowledge
We surveyed 150 endocrinologists—30 from each EU5 country (France, Italy, Germany, Spain, UK)—chosen from the largest community of validated physicians in the world.
All respondents have:
Been practicing for 2+ years
Prescribed at least one of the listed products
Seen at least 5 patients with melanoma in total in the last month
We conducted the survey between May 6th and 10th, 2016.
MONEY BACK GUARANTEE!
At FirstWord, we stand behind our reports. If you're not completely satisfied, we’ll refund your money. Guaranteed.
Table of Contents
Following are different modes of Licenses.
a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.
b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.
c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.
1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :
a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]
b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]
2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:
a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.